
Laxmi Dental (LAXMIDENTL) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Income Metrics
Balance Sheet Metrics
Total Assets
2.8B
Total Liabilities
759.6M
Shareholders Equity
2.1B
Debt to Equity
0.36
Cash Flow Metrics
Revenue & Profitability Trend
Laxmi Dental Income Statement From 2022 to 2025
Metric | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Revenue | 2.4B | 1.9B | 1.6B | 1.3B |
Cost of Goods Sold | 572.4M | 484.9M | 426.6M | 400.2M |
Gross Profit | 1.8B | 1.4B | 1.2B | 894.6M |
Gross Margin % | 75.8% | 74.7% | 73.2% | 69.1% |
Operating Expenses | ||||
Research & Development | - | - | - | - |
Selling, General & Administrative | - | 226.7M | 215.6M | 146.4M |
Other Operating Expenses | 542.2M | 497.6M | 182.9M | 181.6M |
Total Operating Expenses | 542.2M | 724.3M | 398.5M | 328.0M |
Operating Income | 268.5M | 118.5M | 2.2M | -21.4M |
Operating Margin % | 11.4% | 6.2% | 0.1% | -1.7% |
Non-Operating Items | ||||
Interest Income | - | 1.7M | 1.7M | 2.5M |
Interest Expense | 53.9M | 49.5M | 40.9M | 35.7M |
Other Non-Operating Income | - | - | - | - |
Pre-tax Income | 318.3M | 85.2M | -42.6M | -147.1M |
Income Tax | 64.5M | -94.2M | 1.9M | 23.7M |
Effective Tax Rate % | 20.3% | -110.5% | 0.0% | 0.0% |
Net Income | 318.3M | 252.3M | -41.6M | -186.8M |
Net Margin % | 13.5% | 13.2% | -2.6% | -14.4% |
Key Metrics | ||||
EBITDA | 452.1M | 255.0M | 125.2M | -26.2M |
EPS (Basic) | ₹6.07 | ₹4.51 | ₹-0.72 | ₹-3.34 |
EPS (Diluted) | ₹6.05 | ₹4.51 | ₹-0.72 | ₹-3.34 |
Basic Shares Outstanding | 52341021 | 54962149 | 54962149 | 54962149 |
Diluted Shares Outstanding | 52341021 | 54962149 | 54962149 | 54962149 |
Income Statement Trend
Laxmi Dental Balance Sheet From 2022 to 2025
Metric | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Assets | ||||
Current Assets | ||||
Cash & Equivalents | 908.2M | 7.0M | 9.6M | 10.5M |
Short-term Investments | 246.5M | 2.8M | 6.2M | 3.8M |
Accounts Receivable | 366.8M | 249.0M | 204.2M | 203.6M |
Inventory | 186.5M | 247.2M | 242.3M | 295.0M |
Other Current Assets | 160.9M | - | 150.0K | 5.7M |
Total Current Assets | 1.9B | 691.0M | 531.6M | 598.6M |
Non-Current Assets | ||||
Property, Plant & Equipment | 489.2M | 178.4M | 134.6M | 116.7M |
Goodwill | 18.2M | 16.2M | 11.4M | 2.8M |
Intangible Assets | 18.2M | 16.2M | 11.4M | 2.8M |
Long-term Investments | - | - | - | - |
Other Non-Current Assets | - | -20.0K | - | - |
Total Non-Current Assets | 976.1M | 654.2M | 433.7M | 428.9M |
Total Assets | 2.8B | 1.3B | 965.4M | 1.0B |
Liabilities | ||||
Current Liabilities | ||||
Accounts Payable | 320.6M | 158.1M | 225.1M | 266.4M |
Short-term Debt | 42.5M | 312.6M | 233.4M | 221.0M |
Current Portion of Long-term Debt | - | - | - | - |
Other Current Liabilities | 110.8M | 10.0K | - | 40.0K |
Total Current Liabilities | 567.0M | 670.9M | 572.7M | 593.9M |
Non-Current Liabilities | ||||
Long-term Debt | 152.6M | 185.2M | 153.7M | 165.9M |
Deferred Tax Liabilities | - | - | - | - |
Other Non-Current Liabilities | - | -10.0K | - | - |
Total Non-Current Liabilities | 192.6M | 228.6M | 197.9M | 204.1M |
Total Liabilities | 759.6M | 899.5M | 770.6M | 798.0M |
Equity | ||||
Common Stock | 109.9M | 3.1M | 3.1M | 3.1M |
Retained Earnings | - | -232.0M | -480.5M | -450.0M |
Treasury Stock | - | - | - | - |
Other Equity | - | - | - | - |
Total Shareholders Equity | 2.1B | 445.7M | 194.8M | 229.4M |
Key Metrics | ||||
Total Debt | 195.1M | 497.8M | 387.1M | 386.8M |
Working Capital | 1.3B | 20.1M | -41.0M | 4.7M |
Balance Sheet Composition
Laxmi Dental Cash Flow Statement From 2022 to 2025
Metric | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Operating Activities | ||||
Net Income | 310.2M | 69.2M | -45.8M | -161.6M |
Depreciation & Amortization | - | - | - | - |
Stock-Based Compensation | 21.9M | 0 | - | - |
Working Capital Changes | -103.8M | -98.9M | 72.4M | -148.8M |
Operating Cash Flow | 267.5M | 18.3M | 65.9M | -277.3M |
Investing Activities | ||||
Capital Expenditures | -143.7M | -126.7M | -84.7M | 18.6M |
Acquisitions | 25.5M | 36.3M | - | - |
Investment Purchases | -244.2M | 0 | -3.5M | -300.0K |
Investment Sales | - | - | - | - |
Investing Cash Flow | -379.5M | -90.4M | -88.2M | 18.2M |
Financing Activities | ||||
Share Repurchases | - | - | - | - |
Dividends Paid | - | - | - | - |
Debt Issuance | 0 | 97.8M | 35.4M | 70.8M |
Debt Repayment | -338.0M | -82.1M | -34.6M | -99.2M |
Financing Cash Flow | 953.2M | 42.7M | 55.9M | 17.9M |
Free Cash Flow | 277.5M | -66.1M | 44.6M | -116.1M |
Net Change in Cash | 841.2M | -29.4M | 33.6M | -241.1M |
Cash Flow Trend
Laxmi Dental Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
64.42
Forward P/E
30.12
Price to Book
10.33
Price to Sales
9.14
PEG Ratio
1.86
Profitability Ratios
Profit Margin
13.29%
Operating Margin
11.30%
Return on Equity
25.70%
Return on Assets
8.01%
Financial Health
Current Ratio
3.30
Debt to Equity
9.35
Per Share Data
EPS (TTM)
₹6.17
Book Value per Share
₹38.47
Revenue per Share
₹45.68
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
laxmidentl | 21.8B | 64.42 | 10.33 | 25.70% | 13.29% | 9.35 |
Poly Medicure | 195.3B | 56.51 | 7.17 | 15.99% | 20.28% | 6.52 |
Dr Agarwal's Health | 140.4B | 625.56 | 7.45 | 6.61% | 4.88% | 49.87 |
Tarsons Products | 19.9B | 66.74 | 3.15 | 4.79% | 7.59% | 53.82 |
Prevest Denpro | 6.7B | 36.86 | 6.35 | 18.70% | 28.81% | 0.00 |
Centennial Surgical | 558.2M | 2,482.50 | 1.82 | -4.65% | -2.74% | 108.97 |
Financial data is updated regularly. All figures are in the company's reporting currency.